University of Pittsburgh - of the Commonwealth System of Highter Education
University of Pittsburgh - of the Commonwealth System of Highter Education Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20150056217 | USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OR PREVENTION OF TOLL-LIKE RECEPTOR-4 ASSOCIATED DISORDERS - The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis. | 02-26-2015 |